Cargando…
Restricted autologous lymphocytotoxicity in lung neoplasia.
Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions wer...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1978
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009731/ https://www.ncbi.nlm.nih.gov/pubmed/81674 |
_version_ | 1782136175351300096 |
---|---|
author | Vose, B. M. Vánky, F. Fopp, M. Klein, E. |
author_facet | Vose, B. M. Vánky, F. Fopp, M. Klein, E. |
author_sort | Vose, B. M. |
collection | PubMed |
description | Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions were only rarely detected (2/32 positive against lung and 1/13 positive against non-lung cells). The restriction of cytotoxicity to the autologous combination was also apparent in in vitro-generated effectors. Blood lymphocytes were co-cultivated with autologous tumour and subsequently tested against autologous or allogeneic targets. Cytotoxicity was found in 13/17 lung tumours against autologous tumour, with no reactions recorded against allogeneic tumour targets, but one case positive against the K562 cell line. These data suggest either the expression of individually distinct antigens on human pulmonary neoplasms, or the requirement for histocompatibility between target and effector in cytotoxicity reactions in man, and therefore differ from previously described patterns of lymphocytotoxicity against human tumours. |
format | Text |
id | pubmed-2009731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1978 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20097312009-09-10 Restricted autologous lymphocytotoxicity in lung neoplasia. Vose, B. M. Vánky, F. Fopp, M. Klein, E. Br J Cancer Research Article Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions were only rarely detected (2/32 positive against lung and 1/13 positive against non-lung cells). The restriction of cytotoxicity to the autologous combination was also apparent in in vitro-generated effectors. Blood lymphocytes were co-cultivated with autologous tumour and subsequently tested against autologous or allogeneic targets. Cytotoxicity was found in 13/17 lung tumours against autologous tumour, with no reactions recorded against allogeneic tumour targets, but one case positive against the K562 cell line. These data suggest either the expression of individually distinct antigens on human pulmonary neoplasms, or the requirement for histocompatibility between target and effector in cytotoxicity reactions in man, and therefore differ from previously described patterns of lymphocytotoxicity against human tumours. Nature Publishing Group 1978-09 /pmc/articles/PMC2009731/ /pubmed/81674 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Vose, B. M. Vánky, F. Fopp, M. Klein, E. Restricted autologous lymphocytotoxicity in lung neoplasia. |
title | Restricted autologous lymphocytotoxicity in lung neoplasia. |
title_full | Restricted autologous lymphocytotoxicity in lung neoplasia. |
title_fullStr | Restricted autologous lymphocytotoxicity in lung neoplasia. |
title_full_unstemmed | Restricted autologous lymphocytotoxicity in lung neoplasia. |
title_short | Restricted autologous lymphocytotoxicity in lung neoplasia. |
title_sort | restricted autologous lymphocytotoxicity in lung neoplasia. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009731/ https://www.ncbi.nlm.nih.gov/pubmed/81674 |
work_keys_str_mv | AT vosebm restrictedautologouslymphocytotoxicityinlungneoplasia AT vankyf restrictedautologouslymphocytotoxicityinlungneoplasia AT foppm restrictedautologouslymphocytotoxicityinlungneoplasia AT kleine restrictedautologouslymphocytotoxicityinlungneoplasia |